Clare M Adams

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Network Analysis

Chronic Lymphocytic Leukemia

Top Venues

Cancer research communications

Cancer discovery

Molecular & cellular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Clare M Adams, Amanda McBride, Peter Michener, Irina Shkundina, Ramkrishna Mitra, Hyun Hwan An, Pierluigi Porcu, Christine M Eischen
Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma. Cancers 16 (11) (2024)
Clare M Adams, Amanda McBride, Peter Michener, Irina Shkundina, Ramkrishna Mitra, Hyun Hwan An, Pierluigi Porcu, Christine M Eischen
Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma. Cancers 16 (11) (2024)
Clare M Adams, Amanda McBride, Peter Michener, Irina Shkundina, Ramkrishna Mitra, Hyun Hwan An, Pierluigi Porcu, Christine M Eischen
Identifying Targetable Vulnerabilities to Circumvent or Overcome Venetoclax Resistance in Diffuse Large B-Cell Lymphoma. Cancers 16 (11) (2024)
Ramkrishna Mitra, Clare M Adams, Christine M Eischen
Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. Cancer research communications 3 (5) (2023)
Ramkrishna Mitra, Clare M Adams, Christine M Eischen
Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. Cancer research communications 3 (5) (2023)
Ramkrishna Mitra, Clare M Adams, Christine M Eischen
Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. Cancer research communications 3 (5) (2023)
Ramkrishna Mitra, Clare M Adams, Christine M Eischen
Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. Cancer research communications 3 (5) (2023)
Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams, Magali Saez-Ayala, Tatiana Kent, Mrityunjay Tyagi, V S S Abhinav Ayyadevara, Yifan Wang, John J Krais, John Gordon, Jessica Atkins, Monika Maria Toma, Stéphane Betzi, Andrew S Boghossian, Matthew G Rees, Melissa A Ronan, Jennifer A Roth, Aaron R Goldman, Nicole Gorman, Ramkrishna Mitra, Wayne E Childers, Xavier Graña, Tomasz Skorski, Neil Johnson, Christian Hurtz, Xavier Morelli, Christine M Eischen, Richard T Pomerantz
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress. Molecular cancer therapeutics (2023)
Clare M Adams, Ramkrishna Mitra, You-Cai Xiao, Peter Michener, Juan Palazzo, Allen Chao, Jitendra Gour, Joel A Cassel, Joseph M Salvino, Christine M Eischen
Targeted MDM2 degradation reveals a new vulnerability for p53 inactivated triple negative breast cancer. Cancer discovery (2023)
Ramkrishna Mitra, Clare M Adams, Christine M Eischen
Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. Cancer research communications 3 (5) (2023)
Clare M Adams, Ramkrishna Mitra, You-Cai Xiao, Peter Michener, Juan Palazzo, Allen Chao, Jitendra Gour, Joel A Cassel, Joseph M Salvino, Christine M Eischen
Targeted MDM2 degradation reveals a new vulnerability for p53 inactivated triple negative breast cancer. Cancer discovery (2023)
Ramkrishna Mitra, Clare M Adams, Christine M Eischen
Systematic lncRNA mapping to genome-wide co-essential modules uncovers cancer dependency on uncharacterized lncRNAs. eLife 11 (2022)
Ramkrishna Mitra, Clare M Adams, Wei Jiang, Evan Greenawalt, Christine M Eischen
Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival. Nature communications 11 (1) (2020)
Lance R Thomas, Clare M Adams, Stephen W Fesik, Christine M Eischen, William P Tansey
Targeting MYC through WDR5. Molecular & cellular oncology 7 (2) (2020)